期刊文献+

鱼藤素对宫颈癌HeLa细胞生存活力和凋亡的影响 被引量:5

Effect of deguelin on viability and apoptosis of human cervical cancer Hela cells
下载PDF
导出
摘要 目的探讨鱼藤素对人宫颈癌HeLa细胞生存活力和凋亡的影响。方法将不同浓度(0、10、100、500、1 000 nmol/L)的鱼藤素作用于HeLa细胞24、48和72 h,磺基罗丹明B(sulforhodamine B,SRB)法检测细胞的生存活力;Hoechst 33258染色法观察细胞形态变化;Annexin V-FITC双标法检测细胞凋亡;流式细胞仪检测细胞周期变化。结果鱼藤素对HeLa细胞的生存活力具有明显抑制作用,且呈现出时间和剂量依赖性;流式细胞仪检测发现鱼藤素对HeLa细胞有诱导凋亡并使细胞周期阻滞在G0/G1期的作用。结论鱼藤素在体外能有效抑制HeLa细胞的生存活力并诱导其凋亡。 【Objective】To investigate the effect of deguelin on viability and apoptosis of human cervical cancer HeLa cell. 【Methods】 Using different concentrations(0, 10, 100, 500, 1 000 nmol/L) of deguelin on HeLa cells at 24 h, 48 h, 72 h. SRB assay was used to detect the cell viability of each group at different times; Hoechst 33258 staining assay was used to observe the morphological changes induced by deguelin; Annexin V-FITC double labeled flow cytometry was used to detect the apoptosis; the cell cycle was analyzed via flow cytometry. 【Results】 The viability of HeLa cells was inhibited by deguelin in a time and dose dependent manner. The flow cytometry results showed that deguelin could induce HeLa cells apoptosis and the cell cycle was arrested in G0/G1 phase. 【Conclusion】 Deguelin can efficiently inhibit the viability and induce apoptosis of Hela cells in vitro.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2014年第17期10-14,共5页 China Journal of Modern Medicine
关键词 鱼藤素 HELA 生存活力 凋亡 deguelin Hela viability apoptosis
  • 相关文献

参考文献12

  • 1刘兵,曾自力,潘平山,滕炳祥.宫颈癌盆腔组织校正对放疗剂量学影响的研究[J].广西医学,2012,34(7):827-830. 被引量:3
  • 2王智宇,张雪玉.764例宫颈癌临床资料分析及治疗模式变化的探讨[J].宁夏医科大学学报,2009,31(1):47-49. 被引量:8
  • 3UDEANI GO, GERHAUSER C, THOMAS CF, et al. Cancer chemopreventive activity mediated by deguelin, a naturally occurring retenoid[J]. Cancer Res, 1997, 57(16): 3424-3428.
  • 4YAN Y, WANG Y, TAN Q, et al. Efficacy of deguelin and sili- binin on benzo(a) pyrene-induced lung tumorigenesis in A/J mice [J]. Neoplasia, 2005, 7(12): 1053-1057.
  • 5OH SH, WOO JK, YAZICI YD, et al. Structural basis for depletion of heat shock protein 90 client proteins by degudin[J]. J Natl Cancer Inst, 2007, 99(12): 949-961.
  • 6CHUN KH, KOSMEDER JW, SUN S, et al. Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells[J]. J Nail Cancer Inst, 2003, 95(4): 291-302.
  • 7MURILLO G, SALTI GI, KOSMEDER JW, et al. Deguelin inhibits the growth of colon cancer cells through the induction of apotosis and cell cycle arrest[J]. Eur J Cancer, 2002, 38(18): 2446-2454.
  • 8张晔,李范,王孝宁,闫雷,刘云鹏.肿瘤学生物信息资源检索及其应用[J].现代生物医学进展,2012,12(24):4738-4740. 被引量:1
  • 9WONG RS. Apoptosis in cancer: from pathogenesis to treatment [J]. J Exp Clin Cancer Res, 2011, 30(1): 87.
  • 10王国宁,米开热木.麦麦提,古扎丽努尔.阿不力孜.异常黑胆质成熟剂总酚与顺铂、多西他赛联合对人宫颈癌SiHa细胞的影响[J].重庆医学,2011,40(18):1769-1771. 被引量:4

二级参考文献47

  • 1朱华,帅茨霞.年轻妇女宫颈癌134例初步分析[J].临床肿瘤学杂志,2004,9(4):383-385. 被引量:21
  • 2奚玲,朱涛,吴鹏,徐茜,黄磊,李科珍,卢运萍,马丁.人端粒酶逆转录酶在子宫颈癌组织中的表达变化及其意义[J].中华妇产科杂志,2005,40(6):407-410. 被引量:15
  • 3郝敏,王静芳.宫颈癌流行病学研究与调查[J].国外医学(妇幼保健分册),2005,16(6):404-406. 被引量:91
  • 4Eifel PJ.Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer[J].Nat Clin Pract Oncol,2006,3(5):248-255.
  • 5Darzynkiewicz Z,Halicka DH,Tanaka T.Cytometric assessment of DNA damage induced by DNA topoisomerase inhibitors[J].Methods Mol Biol,2009(582):145-153.
  • 6Bergqvist M,Brattstr(o)m D,Gullbo J,et al.p53 status and its in vitro relationship to radiosensitivity and chemosensitivity in lung cancer[J].Anticancer Res,2003,23(2B):1207-1212.
  • 7Royle NJ,Méndez-Bermúdez A,Gravani A,et al.The role of recombination in telomere length maintenance[J].Biochem Soc Trans,2009,37(Pt 3):589-595.
  • 8Hopman AH,Theelen W,Hommelberg PP,et al.Geno-mic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer[J].J Pathol,2006,210(4):412-419.
  • 9Wisman GB,Knol AJ,Helder MN,et al.Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer[J].Int J Cancer,2001,91(5):658-664.
  • 10ICRU. Prescribing, recording, and reporting therapy[ R]. ICRU Report No. 50,1993.

共引文献12

同被引文献77

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部